Overview

Transplant Diagnostics Market is poised to value USD 6775.59 million by 2028 end at a CAGR of 7.2% during the forecast period 2022 to 2028.

Rising number of stem-cell-based, soft tissues, and solid transplantation, increasing geriatric population, rising occurrence of persistent diseases, augmentation in laboratory automation of diagnostic operations that are assisted by robots and advancements in technology advancement in human leukocyte antigen typing are some of the crucial factors driving the growth of the global transplant diagnostics market. Additionally, an increase in public and private investments to develop novel human leukocyte antigen (HLA) products for testing, soaring number of HLA applications in diagnostics, improvement in healthcare infrastructure, especially in developing nations, consistent reduction average gene sequencing costs and rising bases of installation of NGS and PCR instruments are steering the global transplant diagnostic market growth.

Although, factors like high NGS and PCR instrument costs, finite medical rendering for transplantation operations and a massive difference between annual transplantation and organ donation are the important factors responsible for impeding market growth.

Increasing penetration of the market in emerging economies in order to develop products of transplant diagnostics and rising priority shift from using serological assay method to HLA profiling based on genomes would open further opportunities for the growth of the transplant diagnostic market. New product developments and product announcements are amongst the primary global market trends.

North America subjugates the global market owing to consistent gene sequencing average cost reduction, public and funding for HLA development and increasing number of solid organ and stem cell-based transplantation in the region. The Asia Pacific region is predicted to showcase a high growth rate in the next decade in the global market with India and China being the fastest escalating markets in the region. The important steering forces for the market in developing economies are large patient pools, improvements in healthcare infrastructure, increasing private and public support in order to develop HLA technologies, and growing emphasis of life science organizations in the region.

Key players included in the global transplant diagnostics industry are Becton, Dickinson and Co., Biofortuna, Biomerieux SA, Bio-Rad Laboratories, Caredx, F.Hoffman-La Roche Ltd., Gendx, Hologic, illumine, Immucor, Luminex, Merck KGaA, Omixon, Qiagen, Thermo Fisher Scientific.

Transplant Diagnostics Market Segmentation:

By Product and Services

Reagents
Instruments
Software and Services

By Technology

• Molecular Assays
o PCR-Based Molecular Assay
• Real-Time PCR
• Sequence-Specifier Primer-PCR
• Sequence-Specific Oligonucleotide-PCR
• Others PCR-Based Molecular Assays
o Sequence-Based Molecular Assays
• Sanger Sequencing
• Next-Generation Sequencing
• Others Sequencing Molecular Assays
• Non-Molecular Assays

By Transplant Type

• Solid Organ Transplant
o Kidney Transplant
o Liver Transplant
o Heart Transplant
o Lung Transplant
o Pancreas Transplant
o Other Organ Transplantations
• Stem Cell Transplant
• Soft Tissue Transplant
• Bone Marrow Transplantation

By Application

• Diagnostic Application
o Pre-Transplantation Diagnostics
• Infectious Disease Testing
• Histocompatibility Testing
• Blood Profiling
o Post-Transplantation Diagnostics
• Research Applications

By End User

Independent Reference Laboratories
Hospitals & Transplant Centres
Research Laboratories & Academic Institutes

By Region

North America
Europe
Asia Pacific
Latin America
Middle East and Africa

Competitive Landscape:

• Tier 1 players- established companies in the market with a major market share
• Tier 2 players
• Emerging players which are growing rapidly
• New Entrants

FutureWise Key Takeaways:

Growth prospects
SWOT analysis
Key trends
Key data-points affecting market growth

Objectives of the Study:

To provide with an exhaustive analysis on the global market by product and services, by technology, by transplant type, by application, by end user and by region
To cater comprehensive information on factors impacting market growth (drivers, restraints, opportunities, and industry-specific restraints)
To evaluate and forecast micro-markets and the overall market
To predict the market size, in key regions (along with countries)— North America, Europe, Asia Pacific, Latin America and Middle East and Africa
To record evaluate and competitive landscape mapping- product launches, technological advancements, mergers and expansions
Profiling of companies to evaluate their market shares, strategies, financials and core competencies

Flexible Delivery Model:

We have a flexible delivery model and you can suggest changes in the scope/table of content as per your requirement
The customization services offered are free of charge with purchase of any license of the report.
You can directly share your requirements/changes to the current table of content to: sales@futurewiseresearch.com